Halogenated indole-3-acetic acids as oxidatively activated prodrugs with potential for targeted cancer therapy

Bioorganic and Medicinal Chemistry Letters

Volumn 12, Issue 18, 2002, Pages 2523-2526

  Rossiter, Sharon ^a   Folkes, Lisa K ^a   Wardman, Peter ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HORSERADISH PEROXIDASE; INDOLEACETIC ACID DERIVATIVE; PRODRUG;

ANIMAL CELL; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG OXIDATION; DRUG POTENCY; HALOGENATION; INCUBATION TIME; LUNG FIBROBLAST; NONHUMAN;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CRICETINAE; HALOGENS; HORSERADISH PEROXIDASE; INDOLEACETIC ACIDS; KINETICS; OXIDATION-REDUCTION; PRODRUGS;

ARMORACIA RUSTICANA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0037119677     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00505-X     Document Type: Article

References (23)

1. Dunford, H. B. In Peroxidases in Chemistry and Biology; Everse, J., Everse, K. E., Grisham, M. B., Eds.; CRC Press: Boca Raton, 1991; Vol. II, pp 1-24.
2. Hinman R.L., Bauman C., Lang J. Biochem. Biophys. Res. Commun. 5:1961;250.
3. Hinman R.L., Lang J. Biochemistry. 4:1965;144.
4. Suzuki Y., Kawarada A. Agric. Biol. Chem. 42:1978;1315.
5. Candeias L.P., Folkes L.K., Dennis M.F., Patel K.B., Everett S.A., Stratford M.R.L., Wardman P. J. Phys. Chem. 98:1994;10131.
6. Still C.C., Fukuyama T.T., Moyed H.S. J. Biol. Chem. 240:1965;2612.
7. Folkes L.K., Candeias L.P., Wardman P. Int. J. Radiat. Oncol. Biol. Phys. 42:1998;917.
8. Folkes L.K., Dennis M.F., Stratford M.R.L., Candeias L.P., Wardman P. Biochem. Pharmacol. 57:1999;375.
9. Folkes L.K., Wardman P. Biochem. Pharmacol. 61:2001;129.
10. Candeias L.P., Folkes L.K., Porssa M., Parrick J., Wardman P. Biochemistry. 35:1996;102.
11. Folkes L.K., Greco O., Dachs G.U., Stratford M.R.L., Wardman P. Biochem. Pharmacol. 63:2002;265.
12. Wardman, P. Curr. Pharm. Des. 2002, 8, 1363.
13. Bullock M.W., Fox S.W. J. Am. Chem. Soc. 73:1951;2756. and 5155.
14. Engvild K.C. Acta Chem. Scand. B. 31:1977;338.
15. Robinson B. Chem. Rev. 63:1963;373.
16. Batcho A.D., Leimgruber W. Org. Synth. 63:1985;214.
17. Carrera G.M., Sheppard G.S. Synlett. 1994;93.
18. Dillard, R. D.; Bach, N. J.; Draheim, S. E.; Berry, D. R.; Carlson, D. G.; Chirgadze, N. Y.; Clawson, D. K.; Hartley, L. W.; Johnson, L. M.; Jones, N. D.; McKinney, E. R.; Mihelich, E. D.; Olkowski, J. L.; Schevitz, R. W.; Smith, A. C.; Snyder, D. W.; Sommers, C. D.; Wery, J.-P. J. Med. Chem. 1996, 39, 5119.
19. Candeias L.P., Folkes L.K., Wardman P. Biochemistry. 36:1997;7081.
20. Greco O., Folkes L.K., Wardman P., Tozer G.M., Dachs G.U. Cancer Gene Ther. 7:2000;1414.
21. Greco O., Rossiter S., Kanthou C., Folkes L.K., Wardman P., Tozer G.M., Dachs G.U. Mol. Cancer Therapeutics. 1:2001;151.
22. Rossiter S. Tetrahedron Lett. 43:2002;4671.
23. Folkes L.K., Rossiter S., Wardman P. Chem. Res. Toxicol. 15:2002;877.